The 12 weeks, randomized, double-blinded, placebo-controlled human study to evaluate the effectiveness and safety of KGC deer antlers on the growth of children

Korea Ginseng Corporation0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年6月27日

试验速览

暂无简介。

•1) Boys and girls aged between 3 and 12
•2) Children who have voluntarily agreed to participate in this study and have written informed consent signed by them or their representative

•1) Endocrine diseases (juvenile diabetes, hyperlipidemia, hypertension)
•2) Diseases retarded growth (growth hormone deficiency due to pituitary disease)
•3) Chromosomal abnormalities
•4) Abnormal appearance
•5) Not born with a normal range of weight (less than 2.6 kg or more than 4.4 kg)
•6) Received hormone replacement therapy, calcitonin, phosphonate, growth hormone treatment within 6 months prior to screening test
•7) Clinically significant acute or chronic disease of cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urological system, neuropsychiatric system, musculoskeletal system, inflammatory and hemato-oncological system, or gastrointestinal system
•8) Taken medicines of health functional foods related to children's height growth within three months prior to screening test
•9) Received antipsychotic medication within three months prior to screening test
•10) Participated in another clinical trial within one month prior to screening test
•11) Determined inappropriate due to other reasons such as clinical laboratory examination

发起方